Supplier's Corner

Syn-tacks from Pentapharm

May 2, 2007

Pentapharm’s new peptide complex Syn-Tacks was unveiled at In-Cosmetics 2007 Paris. The new active ingredient is a highly effective peptide complex for anti-aging treatments to preserve and redesign the Dermal Epidermal Junction (DEJ). Syn-Tacks combines two different peptides and stimulates Laminin V, collagen types IV, VII and XVII and Integrin all at once. This activity achieves the utmost anti-aging benefit for the skin, according to the company. In vivo data show in different studies a significant effect on cellular cohesion and skin tone and elasticity. The product was also very well received and rated by means of an evaluation questionnaire.

More info: www.pentapharm.com
blog comments powered by Disqus
  • The Top 50

    The Top 50

    June 30, 2016
    A look at the biggest US companies in the global household and personal products industry.

  • Take Notice

    Take Notice

    Melissa Meisel , Associate Editor||June 1, 2016
    Packaging trends revolve around trendy artwork, eco-conscious materials—and portability is a plus too!

  • Virtual Reality

    Virtual Reality

    Christine Esposito, Associate Editor||June 1, 2016
    An update on nature-identical ingredients for cosmetics and personal care products.

  • Patent Update

    Patent Update

    June 30, 2016
    J&J's anti-aging patent, LVMH and cannabis essential oil, transdermal botulinum toxins and more in recent patent news.

  • Start Stuffing The Ballot Box (Again)!

    Start Stuffing The Ballot Box (Again)!

    June 28, 2016
    Vote on the finalists in Happi's reader's choice Anti-Aging Product of the Year contest!

  • What

    What's Next for the UK?

    Sarah Boumphrey, Euromonitor International||June 27, 2016
    Euromonitor weighs in on how Brexit could impact consumer product companies.